Triple
T16952555
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Ambien |
E411218
|
entity |
| Predicate | brandVariant |
P64697
|
FINISHED |
| Object | Ambien CR |
E411218
|
NE FINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Ambien CR | Statement: [Ambien, brandVariant, Ambien CR]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Ambien CR Context triple: [Ambien, brandVariant, Ambien CR]
-
A.
Ambien
chosen
Ambien is a widely prescribed sedative-hypnotic medication (generic name zolpidem) used short-term to treat insomnia by helping people fall asleep more quickly.
-
B.
Daypro
Daypro is a prescription nonsteroidal anti-inflammatory drug (NSAID) containing oxaprozin, used to relieve pain and inflammation in conditions such as osteoarthritis and rheumatoid arthritis.
-
C.
Kalydeco
Kalydeco is a prescription medication used to treat certain forms of cystic fibrosis by improving the function of defective CFTR proteins.
-
D.
Andexxa
Andexxa is a recombinant modified human factor Xa protein used as a reversal agent to counteract the anticoagulant effects of factor Xa inhibitors such as rivaroxaban and apixaban.
-
E.
Acomplia
Acomplia is the brand name for rimonabant, a cannabinoid receptor antagonist that was developed as an anti-obesity drug but withdrawn due to psychiatric side effects.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: brandVariant Context triple: [Ambien, brandVariant, Ambien CR]
-
A.
brandNameVariant
Indicates that one brand name is an alternative or variant form of another brand name, such as a spelling, regional, or stylistic variation.
-
B.
bodyVariant
Indicates that one entity is an alternative physical form or version of another entity’s body.
-
C.
brandAttribute
Indicates that a specific attribute or characteristic is associated with, or describes, a particular brand.
-
D.
brandLanguageVariant
Indicates that one language variant of a brand is related to or derived from another language version of the same brand.
-
E.
productVariant
chosen
Indicates that one entity is a specific variant or version of a more general product entity.
- F. None of above.
Provenance (4 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d886c9c9d481909afe222093641cae |
completed | April 10, 2026, 5:12 a.m. |
| NER | Named-entity recognition | batch_69e3d0197f308190af7185fc9cc7a6e9 |
completed | April 18, 2026, 6:40 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_6a00d46213b08190b33b48d12bc795d1 |
completed | May 10, 2026, 6:54 p.m. |
| PD | Predicate disambiguation | batch_69e32b9aa8748190b248890aca86753d |
completed | April 18, 2026, 6:58 a.m. |
Created at: April 10, 2026, 5:31 a.m.